Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-06-27
1997-03-18
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514542, 514563, 514615, 558416, 560 34, 562439, 564149, C07C24338, C07C25546, A61K 31165, A61K 31275
Patent
active
056123736
ABSTRACT:
The invention concerns acid derivatives of formula I
REFERENCES:
patent: 5039805 (1991-08-01), Alig et al.
patent: 5084466 (1992-01-01), Alig et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5254573 (1993-10-01), Bovy et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5276049 (1994-01-01), Himmelsbach et al.
patent: 5281585 (1994-01-01), Duggan et al.
Alig, et al., "Low Molecular Weight, Non-peptide Fibrinogen Receptor Antagonists", J. Med. Chem., 1992, 35, 4393-4407.
Hartman, et al., "Non-peptide Fibrinogen Receptor Antagonists 1. Discovery and Design of Exosite Inhibitors", J. Med. Chem., 1992, 35, 4640-4642.
Brewster Andrew G.
Caulkett Peter W. R.
Faull Alan W.
Pearce Robert J.
Shute Richard E.
Rotman Alan L.
Zeneca Limited
LandOfFree
Certain diacyl hydrazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain diacyl hydrazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain diacyl hydrazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1706700